CSS LLC’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-194,903
Closed -$29.5M 1321
2022
Q3
$29.5M Buy
194,903
+190,903
+4,773% +$28.3M 1.39% 10
2022
Q2
$583K Buy
+4,000
New +$511K 0.02% 535
2020
Q2
Sell
-2,781
Closed -$148K 830
2020
Q1
$95K Buy
+2,781
New +$127K 0.01% 499

Other funds holding BHVN

CSS LLC's BHVN Position: Q4 2022 in Review

CSS LLC sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 194,903 shares — an estimated $29.5M sold.

CSS LLC first reported a position in BHVN in Q1 2020 and held it in 3 quarters. The position peaked at $29.5M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • CSS LLC reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 194,903 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $29.5M.
  • CSS LLC first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2020 and held it in 3 quarters.
  • CSS LLC's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $29.5M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.